Christine K. Gause
- Oncology top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Otorhinolaryngology top 1%
- Molecular Biology
- Co-authors
- Laura Q.M. ChowRaanan BergerJonathan D. ChengBarbara BurtnessTanguy Y. SeiwertJoseph P. EderJared WeissKarl Heath
- Topics
- Cancer Immunotherapy and Biomarkers (21 papers)CAR-T cell therapy research (6 papers)Advanced Breast Cancer Therapies (4 papers)
- Partner nations
- United StatesIsraelFrance
In The Last Decade
Christine K. Gause
37 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 1.6k
- Immunology 613
- Pulmonary and Respiratory Medicine 523
- Otorhinolaryngology 403
- Molecular Biology 379
Countries citing papers authored by Christine K. Gause
This map shows the geographic impact of Christine K. Gause's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine K. Gause with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine K. Gause more than expected).
Fields of papers citing papers by Christine K. Gause
This network shows the impact of papers produced by Christine K. Gause. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine K. Gause. The network helps show where Christine K. Gause may publish in the future.
Co-authorship network of co-authors of Christine K. Gause
This figure shows the co-authorship network connecting the top 25 collaborators of Christine K. Gause. A scholar is included among the top collaborators of Christine K. Gause based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine K. Gause. Christine K. Gause is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 16 | |
| 3 | 21 | |
| 4 | 3 | |
| 5 | Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialbreakdown → | 1275 |
| 6 | 23 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 9 | |
| 10 | 28 | |
| 11 | 11 | |
| 12 | 1 | |
| 13 | 41 | |
| 14 | 19 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 25 | |
| 18 | 13 | |
| 19 | 12 | |
| 20 | 8 |
About Christine K. Gause
Christine K. Gause is a scholar working on Oncology, Otorhinolaryngology and Hematology, having authored 38 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), CAR-T cell therapy research (6 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Otorhinolaryngology (403 citations), Oncology (1.6k citations) and Immunology (613 citations). Christine K. Gause has collaborated with scholars based in United States, Israel and France. Frequent co-authors include Laura Q.M. Chow, Raanan Berger, Jonathan D. Cheng, Barbara Burtness, Tanguy Y. Seiwert, Joseph P. Eder, Jared Weiss, Karl Heath, Jared Lunceford and Terrill K. McClanahan. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.